Genmab A/S - Strategy and SWOT Report,
- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Genmab A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genmab A/S in the form of a SWOT analysis
- An in-depth view of the business model of Genmab A/S including a breakdown and examination of key business segments
- Intelligence on Genmab A/S’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genmab A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 157 people as of December 31, 2013.
Reasons to Purchase:Gain understanding of Genmab A/S and the factors that influence its strategies Track strategic initiatives of the company and latest corporate news and actions Assess Genmab A/S as a prospective partner, vendor or supplierSupport sales activities by understanding your customers' businesses betterStay up to date on Genmab A/S’s business structure, strategy and prospects
- Company Snapshot
- Genmab A/S: Company Overview
- Genmab A/S: Overview and Key Facts
- Genmab A/S: Overview
- Genmab A/S: Key Facts
- Genmab A/S: Key Employees
- Genmab A/S: Key Employee Biographies
- Genmab A/S: Major Products and Services
- Genmab A/S: Company History
- Genmab A/S: Management Statement
- Genmab A/S: Locations and Subsidiaries
- Genmab A/S: Key Competitors
- Genmab A/S: Company Analysis
- Genmab A/S: Business Description
- Genmab A/S: SWOT Analysis
- Genmab A/S: SWOT Overview
- Genmab A/S: Strengths
- Genmab A/S: Weaknesses
- Genmab A/S: Opportunities
- Genmab A/S: Threats
- Genmab A/S: Corporate Financial Deals Activity
- Genmab A/S: Financial Deals Overview
- Genmab A/S: Targets and Partners
- Genmab A/S: Top Deals 2011 - 2015YTD*
- Genmab A/S: Capital Raising
- Genmab A/S: Partnership
- Genmab A/S: Divestments
- Genmab A/S: Private Equity and Ownership
- Genmab A/S: Recent Developments
- Genmab A/S: News and Events Summary
- Genmab A/S: Business Expansion
- Genmab A/S: Corporate Governance
- Genmab A/S: Financial Performance
- Genmab A/S: Regulatory and Legal Events
- Genmab A/S: Research & Development
- Genmab A/S: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- Definitions
- About Market Line
- List of Tables
- Table 1: Genmab A/S: Key Facts
- Table 2: Genmab A/S: Key Employees
- Table 4: Genmab A/S: Key Competitors
- Table 5: Genmab A/S: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Genmab A/S: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Table 7: Genmab A/S: Targets and Partners
- Table 8: Genmab A/S: Top Deals 2011 - 2015YTD*
- Table 9: Genmab A/S: Capital Raising Volume and Value Trend (2011 - YTD*2015)
- Table 10: Genmab A/S: Capital Raising by Deal Type (2011 - YTD*2015)
- Table 11: Genmab A/S: Partnership Volume and Value Trend (2011 - YTD*2015)
- Table 12: Genmab A/S: Partnership Trend by Deal Type (2011 - YTD*2015)
- Table 13: Genmab A/S: Divestments Volume and Value Trend (2011 - YTD*2015)
- Table 14: Genmab A/S: Divestments by Geography (2011 - YTD*2015)
- Table 15: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
- Table 16: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
- Table 17: Genmab A/S: News and Events Summary
- Table 18: Genmab A/S: Business Expansion
- Table 19: Genmab A/S: Corporate Governance
- Table 20: Genmab A/S: Financial Performance
- Table 21: Genmab A/S: Regulatory and Legal Events
- Table 22: Genmab A/S: Research & Development
- Table 23: Genmab A/S: Strategy and Operations
- List of Figures
- Figure 1: Genmab A/S: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Genmab A/S: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Figure 3: Genmab A/S: Capital Raising Volume and Value Trend (2011 - YTD*2015)
- Figure 4: Genmab A/S: Capital Raising by Deal Type (2011 - YTD*2015)
- Figure 5: Genmab A/S: Partnership Volume and Value Trend (2011 - YTD*2015)
- Figure 6: Genmab A/S: Partnership Trend by Deal Type (2011 - YTD*2015)
- Figure 7: Genmab A/S: Divestments Volume and Value Trend (2011 - YTD*2015)
- Figure 8: Genmab A/S: Divestments by Geography (2011 - YTD*2015)
- Figure 9: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
- Figure 10: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)